Last reviewed · How we verify
¹³C₈-LY2835219
At a glance
| Generic name | ¹³C₈-LY2835219 |
|---|
| Sponsor | Eli Lilly and Company |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.